Pfizer Won&#39;t Let Go
524656
The cardiovascular risk boogeyman is everywhere. First it struck Merck&#39;s (NYSE: MRK) Vioxx. Then Pfizer&#39;s (NYSE: PFE) Celebrex.
402524
New York - Pfizer, the world&#39;s largest drug maker, is discussing with US regulators whether to add a stronger warning to its Bextra painkiller about rare, serious skin reactions.
732193
* The world&#39;s biggest drug company loses $25 billion in market value in one day as investors fear another Vioxx debacle. NEW YORK - Pfizer Inc.
247867
Pfizer on Sunday reaffirmed its commitment to Celebrex, its blockbuster prescription medication for pain and inflammation from arthritis, despite a disclosure last week that the drug had increased the risk of heart attacks, strokes and death among some
143159
Some analysts are betting Pfizer Inc.  PFE.N won't have to withdraw its arthritis drug Celebrex but  they do expect sales to fall after a study of the drug in  cancer patients showed it increased the risk of heart attacks.
147168
The approval of a new drug is a long-term opportunity.
69221
Although advertising will be suspended indefinitely, Pfizer plans to continue marketing Celebrex to doctors.
435276
The troubled pharmaceutical company begins to show signs of life.
499909
Pfizer Inc., the world&#39;s biggest drugmaker, may benefit from Merck &amp; Co.&#39;s withdrawal of Vioxx because Pfizer&#39;s competing pain medicine Celebrex hasn&#39;t been linked to increased risk of heart attacks and strokes.
113061
Pfizer Inc. PFE.N  said on Tuesday  its experimental drug for a deadly form of stomach cancer  proved safe and effective in a late-stage trial, prompting  researchers to halt the study seven months ahead of schedule.
469619
The world's largest drug firm reports strong  profits despite a fall in Viagra sales  but  it warns that next year's profits will be hit by the expiry of  patents.
190069
The FDA issues a health advisory for a top Pfizer drug.
681063
U.S. patent officials have initially rejected claims for the basic patent on Pfizer Inc's blockbuster Lipitor cholesterol treatment, although the drug maker said on Monday it remained confident the patent would ultimately be upheld.
158108
Pfizer Inc , the world's biggest drug maker, on Wednesday reported fourth-quarter results that beat expectations, sending its shares higher in premarket trading.
114399
Pfizer Inc., the world&#39;s biggest drugmaker, defended its painkiller Celebrex after a researcher&#39;s suggestion the medication may be linked to heart risks sent the stock down as much as 8.3 percent.
280448
Pfizer Inc., the world's largest drug company, said Wednesday that its net income for the fourth quarter more than quadrupled, driven by strong sales of cholesterol drug Lipitor. Its earnings missed analysts' forecasts after excluding certain items, however.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.